Meng X - Search Results

1

MiR-204 suppresses the progression of acute myeloid leukemia through HGF/c-Met pathway.

Nie D, Ma P, Chen Y, Zhao H, Liu L, Xin D, Cao W, Wang F, Meng X, Liu L, Xie M, Sun L. Nie D, et al. Among authors: meng x. Hematology. 2021 Dec;26(1):931-939. doi: 10.1080/16078454.2021.1981533. Hematology. 2021. PMID: 34789086

2

[Clinical features and survival analysis of patients with CD20 positive adult B-lineage acute lymphoblastic leukemia].

Ma J, Sun H, Chen SM, Liu LX, Chen SQ, Liu YF, Xie XS, Meng XL, Deng M, Zhang QT, Li T. Ma J, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Apr;18(2):477-81. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010. PMID: 20416193 Chinese.

3

[Immunophenotyping characteristics of adult patients with acute lymphoblastic leukemia in different ages].

Ma J, Liu YF, Chen SM, Zhang QT, Sun L, Liu LX, Wan DM, Chen SQ, Xie XS, Meng XL, Jiang ZX, Cheng YD, Wang F, Sun H. Ma J, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Aug;18(4):942-5. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010. PMID: 20723305 Chinese.

4

[Clinical observation of thalidomide combined with VAD regimen for treatment of osteosclerotic myeloma (POEMS syndrome)].

Zhou JW, Sun H, Gan SL, Liu YF, Sun L, Wan DM, Meng XL. Zhou JW, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Apr;20(2):348-51. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012. PMID: 22541096 Chinese.

5

[Clinical Characteristics and Therapeutic Efficacy of Multiple Myeloma Combined with Renal Amyloidosis].

Wen HY, Gan SL, Ma J, Xie XS, Liu YF, Jiang ZX, Sun L, Liu LX, Wang F, Meng XL, Chen SQ, Chen YD, Wan DM, Sun H. Wen HY, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Apr;24(2):474-7. doi: 10.7534/j.issn.1009-2137.2016.02.031. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016. PMID: 27151013 Chinese.

6

[PLZF-RARα positive acute promyelocytic leukemia: one case report].

Wen HX, Chen SQ, Wang F, Meng XL, Liu LX, Sun L. Wen HX, et al. Among authors: meng xl. Zhonghua Xue Ye Xue Za Zhi. 2017 Sep 14;38(9):805. doi: 10.3760/cma.j.issn.0253-2727.2017.09.016. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 29081202 Free PMC article. Chinese. No abstract available.

7

Tumor suppressor miR-139-5p targets Tspan3 and regulates the progression of acute myeloid leukemia through the PI3K/Akt pathway.

Zhang R, Tang P, Wang F, Xing Y, Jiang Z, Chen S, Meng X, Liu L, Cao W, Zhao H, Ma P, Chen Y, An C, Sun L. Zhang R, et al. Among authors: meng x. J Cell Biochem. 2019 Mar;120(3):4423-4432. doi: 10.1002/jcb.27728. Epub 2018 Oct 26. J Cell Biochem. 2019. PMID: 30367526

8

[Expression and clinical significance of anti-apoptosis gene, survivin, in acute leukemia].

Lin M, Meng X, Cai Z, Ye X. Lin M, et al. Among authors: meng x. Zhonghua Xue Ye Xue Za Zhi. 2002 May;23(5):251-3. Zhonghua Xue Ye Xue Za Zhi. 2002. PMID: 12133447 Chinese.

9

[The expression of human telomerase reverse transcriptase mRNA and its significance in acute leukemia].

Meng XL, Lin MF, Jin J. Meng XL, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Feb;11(1):30-3. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003. PMID: 12667285 Chinese.

10

[Sensitivity of survivin-positive primary leukemia cells to chemotherapy].

Meng XL. Meng XL. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Apr;13(2):266-8. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005. PMID: 15854289 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,099 results

Search Page